|
Volumn 38, Issue 5, 2013, Pages 523-525
|
Treatment of Darier disease with oral alitretinoin
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALITRETINOIN;
CHOLESTEROL;
EMOLLIENT AGENT;
ETRETIN;
KERATOLYTIC AGENT;
STEROID;
TRIACYLGLYCEROL;
ADULT;
ALOPECIA;
ARTICLE;
CASE REPORT;
CHOLESTEROL BLOOD LEVEL;
DARIER DISEASE;
DRUG INDUCED HEADACHE;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
DRY EYE;
DRY SKIN;
ERYTHEMA;
FEMALE;
GENERAL CONDITION IMPROVEMENT;
HUMAN;
HYPERKERATOSIS;
MULTIPLE CYCLE TREATMENT;
PAPULE;
PATIENT MONITORING;
PRIORITY JOURNAL;
PRURITUS;
QUALITY OF LIFE;
REMISSION;
STEROID THERAPY;
TREATMENT RESPONSE;
TRIACYLGLYCEROL BLOOD LEVEL;
ADMINISTRATION, ORAL;
ADULT;
DARIER DISEASE;
DERMATOLOGIC AGENTS;
FEMALE;
HUMANS;
TREATMENT OUTCOME;
TRETINOIN;
|
EID: 84879219941
PISSN: 03076938
EISSN: 13652230
Source Type: Journal
DOI: 10.1111/ced.12078 Document Type: Article |
Times cited : (37)
|
References (9)
|